Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. - Wikidata - wikimedia - TriplyDB

Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.

Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.

http://www.wikidata.org/entity/Q53347326

about

The Role of PPARs in Cancer The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells Insulin signaling regulates a functional interaction between adenomatous polyposis coli and cytoplasmic dynein.PPARdelta status and mismatch repair mediated neoplasia in the mouse intestine.PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In Vitro Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.A Role for PPARbeta/delta in Tumor Stroma and Tumorigenesis.High expression of Fatty Acid-Binding Protein 5 promotes cell growth and metastatic potential of colorectal cancer cells.Peroxisome proliferator-activated receptors and progression of colorectal cancer.Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression Role of Peroxisome Proliferator-Activated Receptor β/δ and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway.Thiazolidinediones as anti-cancer agents.Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.Peroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1 PPARdelta is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer.Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis.Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease

P2860

Q21342955-B9488902-D4FB-4918-AAFC-82F3CAECF921 Q24601222-C3953BA5-0FBB-4FAB-A720-CA02EC5A87B3 Q27002540-08C7CD22-795E-488C-8D3E-A4CA5CFC220A Q27687166-D045A88A-CDF4-4624-9751-586326A3725B Q28727835-BAB694DE-08C8-457B-8D5B-4C6815C96C10 Q28910200-5A2A23F7-18D4-4AC1-B99A-D12924BDD90A Q33242095-50B9EA6E-BAF1-4CA5-B0D8-560E1DFE34F5 Q33594693-4C0956C9-A957-4A30-8B44-BC27F30B6556 Q33742630-7A70839A-2273-41BF-953E-6ECD642A590A Q33791840-65F133D7-A3F1-411F-8602-3A48128F3B20 Q33806178-80D09C80-6598-46AF-B3A8-63D36C4B9FE8 Q34164353-7D9DC789-3088-479C-96C3-BDEF4E158C59 Q34625038-6C2F2F7D-DA08-404D-91BD-8E442F849290 Q35173520-4C173BB4-2AC3-4BA1-8E3E-254F7BD9BD3D Q35250426-6F20EB73-BFA5-4225-8417-A9E89AD19369 Q35569436-6D52F9E6-454C-45F3-B7E8-2F5371D97C70 Q35613331-CBF49A34-B07B-4F9B-A44F-B4B69275CFF9 Q35878841-D829E6DA-24CB-49C6-B51E-A9485E359526 Q35920285-FE6141D7-4BD4-4733-B5DE-A9B9F223544B Q35939357-A78038F3-D34F-4C59-BE2E-2EEE9A305807 Q35941519-D1E6039A-3D36-49B7-9DE9-0736948B7E03 Q35961671-14EE00E3-9CE5-455B-884D-9F1D440393DD Q36059703-466B7345-1F39-404B-B9C6-BEDEDB4F12F7 Q36352434-0AD0F222-29FC-4363-A5F8-4191D89D88E0 Q36515591-C4A4AA9C-BB8A-45B3-AB3F-44E6720BB044 Q36615627-A1667D24-0302-4085-B7B3-B3F83570FF3F Q36666096-A8FDF7A5-E37C-41A8-BBE5-1D3C34D26315 Q36694384-6DB119B6-6B4B-484C-A9D0-8E325CE28DA9 Q36710291-E1F9E7CC-E916-4C70-B410-78C4F6D21F9E Q36857534-09B9801B-8D50-41D7-A191-B8FBBC859F7C Q36860627-133A3E9B-194C-4089-9B84-44F8F6934E18 Q36923329-05D1B3C9-FADC-454E-9184-03F04B5A4D85 Q37010188-51332EE3-B044-4475-AB2A-7846551597A5 Q37047500-AB666BC7-7D43-40CE-A046-651A8551EEBF Q37142538-06D2B279-A13D-4FB7-AEA5-01CD4B4FF346 Q37144609-8B65EC69-F6B5-434F-BDCE-8E128994F872 Q37166359-C03D792E-D795-425D-BF59-3514DE850477 Q37182798-594AB0AD-D172-4514-8D65-005348BC5387 Q37190455-86AC6A41-BCE5-4C29-9AAD-F2F0FD91FEA6 Q37212217-74161101-966A-4BA6-8EF0-9D3915DCBFFD

P2860

Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.

http://www.wikidata.org/entity/Q53347326

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Ligand activation of peroxisom ...... inhibits colon carcinogenesis.

@en

Ligand activation of peroxisom ...... inhibits colon carcinogenesis.

@nl

type

label

Ligand activation of peroxisom ...... inhibits colon carcinogenesis.

@en

Ligand activation of peroxisom ...... inhibits colon carcinogenesis.

@nl

prefLabel

Ligand activation of peroxisom ...... inhibits colon carcinogenesis.

@en

Ligand activation of peroxisom ...... inhibits colon carcinogenesis.

@nl

P1433

Q53347326-97BBA347-2A7B-4ACF-A503-16D5ECD9816B

P1476

Q53347326-CFFEC962-28C3-43A7-8F40-D019F1498F79

P2093

Q53347326-18591D67-283C-4CF1-B682-63803FDD7FD6

Q53347326-35808BF6-936B-4C80-876E-C416415F4C85

Q53347326-4E8D73E3-EDCC-4CBA-BD4B-B80F420C8A50

Q53347326-7F742E58-FB68-405B-8A69-6901F3592E46

Q53347326-9308E40F-1F4C-492B-AFB3-443E494D2F66

Q53347326-AF407B16-F568-4463-B964-F1664A968361

P304

Q53347326-ED1E2968-F183-47DC-84D9-0C834E46B3FF

P31

Q53347326-4764EF7A-468B-4828-B636-3FE9CC1DA407

P356

Q53347326-F4BE8864-DAF8-46DD-9AD0-50F04163E00F

P407

Q53347326-9CEB54F1-D1BC-4931-8230-BB18AE2A9259

P433

Q53347326-80E6A76B-1C48-4A7D-9A49-322E4AE073F3

P478

Q53347326-4C7C38E0-3624-46D4-AC08-C557EDE395BD

P50

Q53347326-3645CC31-DB89-44EB-A58B-4D4E963FF743

Q53347326-C4458CD8-FEEF-4A88-B522-8245CA181277

P577

Q53347326-AB4541BE-722D-4FA2-B83F-06D54AE6B98B

P698

Q53347326-5AF35BA8-9EDD-42E3-9E15-2043AEB2C454

P356

0008-5472.CAN-05-4277

P1433

Cancer Research

P1476

Ligand activation of peroxisom ...... inhibits colon carcinogenesis

@en

P2093

Frank J Gonzalez

http://www.w3.org/2001/XMLSchema#string

Holly E Marin

http://www.w3.org/2001/XMLSchema#string

Jerrold M Ward

http://www.w3.org/2001/XMLSchema#string

Marjorie A Peraza

http://www.w3.org/2001/XMLSchema#string

Mary J Kennett

http://www.w3.org/2001/XMLSchema#string

Timothy M Willson

http://www.w3.org/2001/XMLSchema#string

P304

4394-4401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-4277

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16618765

http://www.w3.org/2001/XMLSchema#string